US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Tri-Tech Holding Inc.

0.0000

0.0000

Volume:- -

Turnover:- -

Market Cap:8.45

PE:0.00

High:0.0000

Open:0.0000

Low:0.0000

Close:0.0000

52wk High:0.0000

52wk Low:0.0000

Shares:8.45M

Float Shares:- -

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7496

EPS(LYR):-0.7491

ROE:-13.92%

ROA:-5.19%

PB:0.00

PE(LYR):0.00

Loading ...

Overview Company News Filings

Allurion says early US launch patients lose 8%-11% body weight in first four weeks

Allurion dismisses Deloitte, names CBIZ as new auditor

Allurion net loss widens to $6.1 million in Q1 FY26; revenue drops 47% to $2.9 million

Next Technology posts Q1 FY26 net loss of $105.9 million; revenue rises to $465,228

Allurion launches US commercial treatments, expands provider network and employer partnerships

Next Technology Holding FY25 net income climbs 564.5% to $143.2 million; revenue rises 545.3% to $11.6 million

Allurion FY25 net loss widens to $28.8 million; revenue drops 53% to $15.2 million

Next Technology Holding closes $157 million registered direct offering; common shares priced at $1.10

Next Technology Holding announces $157 million registered direct offering; shares priced at $1.10

Next Technology Holding elects four independent directors and names Hsiu Wu board chairman

Allurion Begins Training and Onboarding U.S. Partner Accounts Ahead of April Shipments

Allurion Appeals NYSE Delisting Notice

Allurion Announces Immediate Exercise of Warrants for $3.0 Million Gross Proceeds

FDA approves Allurion Gastric Balloon System PMA

Next Technology Holding Inc. Announces Date for Upcoming Annual Stockholders Meeting

Allurion Partners with Bionut to Offer Discounted Mounjaro for Combination Weight Loss Therapy

Next Technology Holding Inc. Announces Date for Annual Stockholders Meeting

Allurion Technologies Holdings Inc. Held Annual Shareholder Meeting

Next Technology Holding Inc. Grants $120,000 Severance to Departing Chairman

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TRITF/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRITF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRITF\",,,,,undefined,":{"symbol":"TRITF","market":"US","secType":"STK","nameCN":"Tri-Tech Holding Inc.","latestPrice":0.000001,"timestamp":1781035200000,"preClose":0.000001,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":0,"shares":8449774,"eps":-0.749573,"marketStatus":"Closed","change":0,"latestTime":"06-09 16:00:00 EDT Delay","open":0.000001,"high":0.000001,"low":0.000001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.749573,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1781078400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.000001,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRITF\",,,,,undefined,":{"symbol":"TRITF","floatShares":0,"roa":"-5.19%","roe":"-13.92%","lyrEps":-0.749142,"shares":8449774,"dividePrice":0,"high":0.000001,"amplitude":0,"preClose":0.000001,"low":0.000001,"week52Low":0.000001,"pbRate":"0.00","psRate":"0.00","week52High":0.000001,"institutionHeld":0,"latestPrice":0.000001,"eps":-0.749573,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.749573,"open":0.000001,"prevYearClose":0.000001,"prevWeekClose":0,"prevMonthClose":0,"prevQuarterClose":0,"fiveDayClose":0,"twentyDayClose":0,"sixtyDayClose":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRITF\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRITF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRITF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRITF\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640041943","title":"Allurion says early US launch patients lose 8%-11% body weight in first four weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640041943","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640041943?lang=en_us&edition=fundamental","pubTime":"2026-06-02 21:03","pubTimestamp":1780405401,"startTime":"0","endTime":"0","summary":"Allurion Technologies reported early U.S. launch traction; first Smart Capsule shipments completed in April, with first U.S. patients treated that month.Patients lost 8%-11% of total body weight in the first four weeks, based on early clinical outcomes disclosed.U.S. business expected to grow two-fold within the quarter; treatment sessions forecast to rise four-fold.Over half of quarterly business came from re-ordering accounts; gross margin tracked above internal targets, with the first U.S. launch quarter expected to be profitable.Management estimated about 20 million Americans previously tried GLP-1 medications and discontinued, positioning this as a key target market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technolo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDLbrx4jc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRITF","BK4172","ALUR","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638636175","title":"Allurion dismisses Deloitte, names CBIZ as new auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2638636175","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638636175?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:36","pubTimestamp":1779914195,"startTime":"0","endTime":"0","summary":"Allurion Technologies replaced auditor Deloitte with CBIZ CPAs for fiscal 2026, effective May 20; Deloitte was dismissed May 22.Deloitte’s audit opinions for 2024 and 2025 were clean, with no adverse opinion, disclaimer, or scope or accounting qualifications.Material weaknesses in internal controls persisted in 2024, 2025, and the period to May 22, 2026, including segregation-of-duties, staffing, and IT access controls.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL57cTMD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRITF","BK4172","BK4192","ALUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635307850","title":"Allurion net loss widens to $6.1 million in Q1 FY26; revenue drops 47% to $2.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635307850","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635307850?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:38","pubTimestamp":1778877534,"startTime":"0","endTime":"0","summary":"Allurion Technologies reported a net loss of USD 6.1 million for the three months ended March 31, 2026, widening from a net loss of USD 1.5 million a year earlier.Revenue fell 47% to USD 2.9 million, while operating loss narrowed to USD 3.7 million from USD 7.3 million.Cash and cash equivalents totaled USD 5.1 million at March 31, 2026, with net cash used in operating activities narrowing to USD 3.2 million from USD 9.5 million.FDA granted PMA approval on Feb. 20, 2026 for the Allurion Gastric Balloon System featuring the Allurion Smart Capsule, indicated for adults ages 22-65 with BMI of 30-40.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL4lmcHN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","BK4172","TRITF","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631151607","title":"Next Technology posts Q1 FY26 net loss of $105.9 million; revenue rises to $465,228","url":"https://stock-news.laohu8.com/highlight/detail?id=2631151607","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631151607?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:08","pubTimestamp":1777464509,"startTime":"0","endTime":"0","summary":"Next Technology Holding swung to a net loss of $105.85 million for quarter ended March 31, 2026 from net income of $193.44 million a year earlier.Revenue rose to $465,228 from no revenue, driven by a single commercial customer agreement in smart water-system management.Operating loss widened to $6.64 million as total operating expenses climbed to $6.71 million.Other expense totaled $126.51 million, reflecting an unrealized loss on Bitcoin holdings on a decline in fair value.Liquidity strengthened with cash and cash equivalents of $159.72 million; management expects existing cash, future operating cash flow, and share-issuance proceeds to cover working capital needs and capital expenditures over next 12 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investm","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL32XDZx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","TRITF","NXTT","BK4172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628273728","title":"Allurion launches US commercial treatments, expands provider network and employer partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2628273728","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628273728?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:30","pubTimestamp":1776688234,"startTime":"0","endTime":"0","summary":"Allurion began commercial treatments in United States, marking formal entry into obesity market.Early demand centered on patients discontinuing GLP-1 therapy due to side effects or concerns over long-term use.Company started scaling provider network, citing about 15-minute placement without endoscopy or anesthesia.Allurion began exploring partnerships with self-insured employers to expand access through employer-sponsored coverage.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL4l8d8x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4172","TRITF","ALUR","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624499568","title":"Next Technology Holding FY25 net income climbs 564.5% to $143.2 million; revenue rises 545.3% to $11.6 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624499568","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624499568?lang=en_us&edition=fundamental","pubTime":"2026-04-01 10:18","pubTimestamp":1775009888,"startTime":"0","endTime":"0","summary":"Next Technology Holding posted net income from continuing operations of USD 143.2 million, up 564.5%.Revenue rose to USD 11.6 million, up 545.3%.Digital assets climbed to USD 516.2 million as other income jumped to USD 279.7 million, driven by unrealized gains from Bitcoin appreciation.Company said it expects existing cash, anticipated operating cash flow, net proceeds from ordinary share issuance, and capital allocation strategy to cover working capital and capital needs over next 12 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Next Technology Holding Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL1Rxt9l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTT","BK4172","BK4023","TRITF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623310961","title":"Allurion FY25 net loss widens to $28.8 million; revenue drops 53% to $15.2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623310961","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623310961?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:35","pubTimestamp":1774874117,"startTime":"0","endTime":"0","summary":"Allurion posted net loss of USD 29 million.Cash and cash equivalents totaled USD 5 million as of Dec. 31, 2025, with accumulated deficit at USD 251 million.FDA granted PMA approval for Allurion Gastric Balloon System on Feb. 20, 2026, indicated for adults ages 22–65 with BMI 30–40.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allurion Technologies Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL6Wj7yc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","TRITF","BK4172","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622826218","title":"Next Technology Holding closes $157 million registered direct offering; common shares priced at $1.10","url":"https://stock-news.laohu8.com/highlight/detail?id=2622826218","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622826218?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:04","pubTimestamp":1774613050,"startTime":"0","endTime":"0","summary":"Next Technology said it closed a registered direct offering that raised about USD 157.0 million in gross proceeds.The offering included 71,381,818 common shares priced at USD 1.10 per share.Pre-funded warrants to buy up to 71,381,818 common shares were sold at USD 1.099 per warrant.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Next Technology Holding Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL6T1hK6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTT","TRITF","BK4172","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622079571","title":"Next Technology Holding announces $157 million registered direct offering; shares priced at $1.10","url":"https://stock-news.laohu8.com/highlight/detail?id=2622079571","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622079571?lang=en_us&edition=fundamental","pubTime":"2026-03-25 21:10","pubTimestamp":1774444217,"startTime":"0","endTime":"0","summary":"Next Technology Holding entered a definitive agreement with 20 investors for a registered direct offering expected to raise about $157 million in gross proceeds.The deal includes 71,381,818 shares of common stock priced at $1.10 per share.It also issues pre-funded warrants to purchase up to 71,381,818 shares at $1.099 per pre-funded warrant.The offering is being made under an effective shelf registration statement on Form S-3.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL6hMlWk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","NXTT","BK4112","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","BK4023","SG9999014005.SGD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4585","NDAQ","LU2095319765.USD","IE00BGHQF748.EUR","LU2210149790.SGD","SG9999014021.USD","TRITF","SG9999014039.USD","BK4172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618076131","title":"Next Technology Holding elects four independent directors and names Hsiu Wu board chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2618076131","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618076131?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:04","pubTimestamp":1773317052,"startTime":"0","endTime":"0","summary":"Next Technology Holding said shareholders elected Wenbo Li, Guang Cui, Gwanggeun Jo, and Hsiu Wu to its board at the annual meeting held March 9, 2026. Following the meeting, Hsiu Wu was elected chairman of the board. The board also appointed Wenbo Li, Guang Cui, Gwanggeun Jo, and Hsiu Wu to the audit committee, with Wenbo Li as chair. The same four directors were appointed to the compensation committee, chaired by Guang Cui. They were also appointed to the nominating committee, chaired by Hsiu Wu.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Next Technology Holding Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL7ZyTwg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRITF","NXTT","BK4023","BK4172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618940865","title":"Allurion Begins Training and Onboarding U.S. Partner Accounts Ahead of April Shipments","url":"https://stock-news.laohu8.com/highlight/detail?id=2618940865","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618940865?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:00","pubTimestamp":1773234052,"startTime":"0","endTime":"0","summary":"Allurion began training and onboarding partner accounts across the U.S., including academic medical centers and private practices. The company started manufacturing an FDA-approved product and expects to begin shipping in April. As part of its U.S. launch strategy, Allurion is exploring partnerships with self-insured employers to support benefit coverage for eligible employees and families. Employer-sponsored coverage includes about 165 million Americans, and GLP-1 medications account for 11% of employer insurance claims.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDLRF8RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","BK4192","BK4172","TRITF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616358514","title":"Allurion Appeals NYSE Delisting Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2616358514","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616358514?lang=en_us&edition=fundamental","pubTime":"2026-03-02 22:01","pubTimestamp":1772460078,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. said the NYSE has notified the company it intends to begin delisting proceedings after Allurion failed to show it had regained compliance with the exchange’s continued listing standards tied to stockholders’ equity or market capitalization. Allurion plans to appeal the determination and expects its shares to keep trading on the NYSE during the appeal process; it is also pursuing a plan to regain compliance or move its listing to NYSE American. As part of its next steps, Allurion cited FDA approval received on February 20, 2026, and noted it completed a warrant inducement transaction on February 24, 2026, alongside ongoing talks with creditors and capital-raising efforts, including a previously announced debt-for-preferred-stock exchange agreement with its largest creditor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gene","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDLbGS7vf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","TRITF","BK4172","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613420717","title":"Allurion Announces Immediate Exercise of Warrants for $3.0 Million Gross Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2613420717","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613420717?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:15","pubTimestamp":1771942522,"startTime":"0","endTime":"0","summary":"Allurion Technologies announced a definitive agreement for the immediate cash exercise of certain outstanding warrants to buy up to 2,659,565 common shares at a reduced exercise price of $1.15 per share, generating about $3.0 million in gross proceeds before fees. In exchange, the exercising holders will receive new private-placement warrants for up to 5,319,130 shares, exercisable at $1.15 per share for five years starting after stockholder approval.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL2kZDgs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","TRITF","BK4172","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613787293","title":"FDA approves Allurion Gastric Balloon System PMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2613787293","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613787293?lang=en_us&edition=fundamental","pubTime":"2026-02-23 22:00","pubTimestamp":1771855259,"startTime":"0","endTime":"0","summary":"Allurion Technologies, Inc. said the U.S. Food and Drug Administration has approved its premarket approval application for the Allurion Gastric Balloon System, which includes the Allurion Smart Capsule. The company said the device is intended for patients with a body mass index range of 30 to 40 kg/m and is administered in an office visit without surgery, endoscopy, or anesthesia.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260223:nNDLycLgr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRITF","BK4172","ALUR","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610266620","title":"Next Technology Holding Inc. Announces Date for Upcoming Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2610266620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610266620?lang=en_us&edition=fundamental","pubTime":"2026-02-10 05:23","pubTimestamp":1770672212,"startTime":"0","endTime":"0","summary":"Next Technology Holding Inc. will hold its Annual Meeting of Stockholders on March 9, 2026, at Conference Room A, 4th Floor, No. 9 Queen's Road Central, Central, Hong Kong Special Administrative Region, People's Republic of China. The meeting will include the presentation of matters for stockholder consideration as detailed in the official proxy materials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Next Technology Holding Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL7l9vMb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTT","TRITF","BK4023","BK4172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608740668","title":"Allurion Partners with Bionut to Offer Discounted Mounjaro for Combination Weight Loss Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2608740668","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608740668?lang=en_us&edition=fundamental","pubTime":"2026-02-03 22:01","pubTimestamp":1770127263,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. has announced a partnership with Bionut, a leading obesity care provider in Argentina, and Farmastar, a local pharmacy partner with access to the official supplier of Mounjaro  in Argentina. This collaboration will provide Allurion Program patients with access to discounted Mounjaro, to be used in combination with the Allurion Smart Capsule. The initiative aims to enhance weight loss outcomes by combining the Smart Capsule with low-dose tirzepatide, offering a more affordable and effective therapy option for patients seeking metabolically healthy weight loss. Allurion is also exploring similar partnerships in other regions to expand access to GLP-1-based combination therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inves","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL6jyk9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALUR","TRITF","BK4172","BK4192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593162494","title":"Next Technology Holding Inc. Announces Date for Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2593162494","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593162494?lang=en_us&edition=fundamental","pubTime":"2025-12-23 19:22","pubTimestamp":1766488952,"startTime":"0","endTime":"0","summary":"Next Technology Holding Inc. will hold its Annual Meeting of Stockholders at Conference Room A, 4th Floor, No. 9 Queen's Road Central, Central, Hong Kong Special Administrative Region, People's Republic of China. The meeting will address matters submitted to stockholders as described in the distributed proxy materials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Next Technology Holding Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 23, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL6s4hs9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXTT","TRITF","BK4172","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592719000","title":"Allurion Technologies Holdings Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592719000","media":"Reuters","labels":["shareholding","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592719000?lang=en_us&edition=fundamental","pubTime":"2025-12-20 06:01","pubTimestamp":1766181676,"startTime":"0","endTime":"0","summary":"Allurion Technologies Holdings Inc. held its annual meeting of stockholders on December 18, 2025. Shareholders re-elected Omar Ishrak, M.D., Douglas Hudson, and R. Jason Richey to the Board of Directors. The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025 was ratified. An amendment and restatement of the 2023 Stock Option and Incentive Plan was approved, including an increase in authorized shares, an amended definition of Fully-Diluted Shares Outstanding, a lower non-employee director compensation limit, and an extension of the plan’s term. Shareholders also approved a reverse stock split of the company's common stock within a specified range. All proposals considered at the meeting were approved.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDL1Qks5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4192","ALUR","TRITF","BK4172"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2591164895","title":"Next Technology Holding Inc. Grants $120,000 Severance to Departing Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2591164895","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591164895?lang=en_us&edition=fundamental","pubTime":"2025-12-15 19:01","pubTimestamp":1765796512,"startTime":"0","endTime":"0","summary":"Next Technology Holding Inc. has entered into a Resignation and Release Agreement with Lichen Dong following his resignation as a member of the Board of Directors, Chairman of the Board, and Chairman of the Nominating Committee, effective December 10, 2025. Under the terms of the agreement, Mr. Dong will receive a one-time cash payment of US$120,000 within 90 business days from his resignation date as full and final settlement of all outstanding obligations. The agreement also includes mutual release of claims, non-disparagement covenants, and continued confidentiality obligations for Mr. Dong.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Next Technology Holding Inc. published the original content used to generate this news brief via","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL5VqgD7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRITF","BK4172","BK4023","NXTT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}